Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Comparative Study
. 2025 Jul 22;44(7):115879.
doi: 10.1016/j.celrep.2025.115879. Epub 2025 Jun 24.

Comparative analysis of mouse strains for in vivo induction of reprogramming factors

Affiliations
Free article
Comparative Study

Comparative analysis of mouse strains for in vivo induction of reprogramming factors

Sara Picó et al. Cell Rep. .
Free article

Abstract

In vivo reprogramming through the forced expression of Oct4, Sox2, Klf4, and c-Myc (OSKM) has demonstrated great potential for reversing age-associated phenotypes. However, continuous in vivo OSKM expression has raised safety concerns due to loss of cell identity, decrease in body weight, and premature death. Although cyclic short-term or targeted expression of the reprogramming factors can mitigate some of these detrimental effects, systemic rejuvenation of wild-type mice has remained elusive. To improve the fundamental understanding of in vivo reprogramming, we conduct a comparative analysis of various reprogrammable mouse strains across multiple tissues and organs. In addition, we develop reprogrammable mouse strains by avoiding OSKM expression in specific organs or implementing expression approaches within specific cells, thereby offering safer strategies to induce in vivo reprogramming. We hope that these tools will become valuable resources for future research in this field of research with potential implications to human health.

Keywords: CP: Stem cell research; OSKM; aging; chimeric; in vivo; induction; rejuvenation; reprogramming; safety; strain; survival.

PubMed Disclaimer

Conflict of interest statement

Declaration of interests A.O. is co-founder and shareholder of EPITERNA SA (non-financial interests) and Longevity Consultancy Group (non-financial interests).

Similar articles

Publication types

MeSH terms

LinkOut - more resources